SCYNEXIS INCSCYX

Market cap
$58.04M
P/E ratio
Dec 31,
2014
Dec 31,
2015
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Net loss-4-33-30--12-54-55-33-63
Depreciation and amortization-------01
Stock-based compensation expense--------4
Accretion of investment discount--------0
Amortization of debt issuance costs and discount1-0001112
Fair Value Adjustment of Warrants-10-2-3-1245-30-22
Change in fair value of derivative liabilities-----2211
Noncash operating lease expense for right-of-use asset--------0
Loss on extinguishment of debt-1-----1-2-3-
Prepaid expenses, other assets, deferred costs, and other01-016-31-2-2
Accounts receivable0-0-----11
Inventory-------50
Accounts payable-------3-1
Accrued expenses, other liabilities, and other-------52
Net cash used in operating activities--25-29-25-28-38-49-55-80
Purchase of intangible assets-------10
Purchase of investments--3678854014-27
Net cash used in investing activities-2-22-10-1266-1-27
Proceeds from common stock issued624128103246913947
Payments of offering costs and underwriting discounts and commissions-----3604
Proceeds from loan payable-------305
Payments of loan payable issuance costs-------10
Proceeds from employee stock purchase plan issuances000000000
Repurchase of shares to satisfy tax withholdings--------0-
Proceeds from Convertible Debt-----1610--
Payments of senior convertible notes issuance costs--1--10--
Net cash provided by financing activities-3840102942946749
Net (decrease) increase in cash, cash equivalents, and restricted cash----0305111-59
Cash paid for interest----21125
Cash received for interest--0111001
Capital Expenditures Incurred but Not yet Paid-------0-
Deferred offering and issuance costs included in accounts payable------00-
Deferred offering costs reclassified to additional paid-in capital430000000
Stock Issued-----357-
Common stock issued for Commitment Shares------1--
Reclass of warrant liability to additional paid in capital-------00
Reclass Of Deferred Asset Issuance Of Loan Payable To Debt Discount-------00
Settlement of liability for exercise of warrants-------3-